This is the authors' abstract. We don't add key points for this paper.
Hydantoins are important heterocyclic scaffolds present in a number of pharmaceutically relevant compounds. We report here a practical, scalable and enantioselective Pd-catalyzed asymmetric allylic alkylation (Pd-AAA) approach to diversely substituted enantioenriched hydantoins. The method relies on the use of chiral bench-stable Pd-precatalysts previously developed by our groups. The synthetic utility of the method was further outlined by various successful post-modifications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: